Related Experiment Video
Updated: Jun 1, 2026

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Micro-albuminuria: a predictor of 7-day mortality in acute myocardial infarction
Sanjay K Bandyopadhyay1, Soumitra Ghosh, Ranjana Bandyopadhyay
1Department of Medicine, Nil Ratan Sircar Medical College, Kolkata.
Abstract:
A study was undertaken amog 80 non-diabetic patients of acute myocardial infarction (AMI) admitted within 24 hours of the onset of pain, to investigate the prevalence and significance of microalbuminuria (MA) as a predictor of in-hospital mortality, and also to correlate it with other well-established prognostic markers. Spot urinary albumin-to-creatinine ratio (ACR) was measured in first morning sample on day 1 (D1), day 4 (D4) and/or day 7 (D7). Haemodynamic status was assessed clinically by Killip's class and the ejection fraction was measured by echocardiography on D1, D4, and/or D7. Total 7 days mortality was recorded. MA (>30 microg/mg) was found in 95% of patients on 1,. In the group with higher value of MA (>100 microg/mg) on D1, there was significantly more deaths (p <0.01). Also there was significantly more deaths with static or increasing MA value from D1 to D4/D7 (p <0.01). Increasing or static MA had a positive correlation with deteriorating Killip's class in non-survivors, and also there was a correlation between decrease in left ventricular ejection fraction from D1 to D4/D7 and an increasing trend in MA over that period. Thus, MA was found to be a reliable predictor of short-term in-hospital mortality in AMI.
Insights
Microalbuminuria (MA) is highly prevalent in acute myocardial infarction (AMI) patients. Elevated or persistent MA strongly predicts short-term in-hospital mortality and correlates with poor cardiac function in AMI survivors.
Area of Science:
- Cardiology
- Nephrology
- Biomarkers
Background:
- Acute myocardial infarction (AMI) poses significant mortality risks.
- Identifying reliable prognostic markers for in-hospital mortality is crucial for patient management.
- Microalbuminuria (MA) is increasingly recognized as a potential indicator of endothelial dysfunction and cardiovascular risk.
Purpose of the Study:
- To determine the prevalence of microalbuminuria (MA) in non-diabetic patients with acute myocardial infarction (AMI).
- To investigate the significance of MA as a predictor of short-term in-hospital mortality.
- To correlate MA with established prognostic markers like Killip's class and ejection fraction in AMI patients.
Main Methods:
- A cohort of 80 non-diabetic AMI patients admitted within 24 hours of pain onset was studied.
- Spot urinary albumin-to-creatinine ratio (ACR) was measured on days 1, 4, and/or 7.
- Hemodynamic status (Killip's class) and ejection fraction were assessed, and 7-day mortality was recorded.
Main Results:
- Microalbuminuria (MA) was detected in 95% of patients on day 1.
- Higher MA values (>100 microg/mg) on day 1 were associated with significantly increased mortality (p <0.01).
- Static or increasing MA from day 1 to day 4/7 correlated significantly with higher mortality (p <0.01) and deteriorating Killip's class.
Conclusions:
- Microalbuminuria (MA) is a highly prevalent finding in acute myocardial infarction (AMI) patients.
- MA is a reliable predictor of short-term in-hospital mortality in AMI.
- MA levels correlate with impaired cardiac function and hemodynamic instability in AMI patients.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Diabetic Nephropathy
Acute Kidney Injury I: Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Acute Coronary Syndrome III: Diagnostic Studies
